Therapeutic roles of heme oxygenase-1 in metabolic diseases: Curcumin and resveratrol analogues as possible inducers of heme oxygenase-1

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Son, Yong ^a   Lee, Ju Hwan ^a   Chung, Hun Taeg ^b   Pae, Hyun Ock ^a  

^a Wonkwang University   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-APOPTOTIC EFFECTS; ANTI-INFLAMMATORIES; CELLULAR MOLECULES; CELLULAR PROTECTION; CHRONIC INFLAMMATION; ENDOPLASMIC RETICULUM STRESS; INSULIN RESISTANCE; THERAPEUTIC POTENTIALS;

CELL MEMBRANES; ELECTRIC RESISTANCE; PORPHYRINS; RESVERATROL;

METABOLISM;

ADIPONECTIN; ANGIOTENSIN; C REACTIVE PROTEIN; CURCUMIN; FIBRINOGEN; GLUCOSE; GLUCOSE TRANSPORTER 4; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXIREDOXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; RESVERATROL; RETINOL BINDING PROTEIN 4; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; DRUG DERIVATIVE; STILBENE DERIVATIVE;

AEROBIC METABOLISM; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; COMPARATIVE STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN SENSITIVITY; KNOCKOUT MOUSE; METABOLIC DISORDER; METABOLIC STRESS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; METABOLISM; ANALOGS AND DERIVATIVES; DRUG EFFECTS; METABOLIC DISEASES;

ANIMALS; CURCUMIN; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; METABOLIC DISEASES; STILBENES;

EID: 84884884530     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/639541     Document Type: Review

References (89)

1. Roberts C. K., Hevener A. L., Barnard R. J., Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Comprehensive Physiology 2013 3 1 1 58
2. Iannucci C. V., Capoccia D., Calabria M., Leonetti F., Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets. Current Pharmaceutical Design 2007 13 21 2148 2168 2-s2.0-34447498966 10.2174/138161207781039571 (Pubitemid 47078770)
3. Santoro N., Weiss R., Metabolic syndrome in youth: current insights and novel serum biomarkers. Biomarkers in Medicine 2012 6 6 719 727 10.2217/bmm.12.85
4. González-Castejón M., Rodriguez-Casado A., Dietary phytochemicals and their potential effects on obesity: a review. Pharmacological Research 2011 64 5 438 455 2-s2.0-80054991836 10.1016/j.phrs.2011.07.004
5. Cherniack E. P., Polyphenols: planting the seeds of treatment for the metabolic syndrome. Nutrition 2011 27 6 617 623 2-s2.0-79955634065 10.1016/j.nut.2010.10.013
6. Piperi C., Adamopoulos C., Dalagiorgou G., Diamanti-Kandarakis E., Papavassiliou A. G., Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. The Journal of Clinical Endocrinology and Metabolism 2012 97 7 2231 2242 10.1210/jc.2011-3408
7. Pae H. O., Son Y., Kim N. H., Jeong H. J., Chang K. C., Chung H., Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide 2010 23 4 251 257 2-s2.0-77958150583 10.1016/j.niox.2010.08.002
8. Kapitulnik J., Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Molecular Pharmacology 2004 66 4 773 779 2-s2.0-4844219758 10.1124/mol.104.002832 (Pubitemid 39319447)
9. Pae H. O., Kim E. C., Chung H. T., Integrative survival response evoked by heme oxygenase-1 and heme metabolites. Journal of Clinical Biochemistry and Nutrition 2008 42 3 197 203 2-s2.0-46249121630 10.3164/jcbn.2008029 (Pubitemid 351913781)
10. Abraham N. G., Heme oxygenase: a target gene for anti-diabetic and obesity. Current Pharmaceutical Design 2008 14 5 412 421 2-s2.0-42049122627 10.2174/138161208783597371 (Pubitemid 351516846)
11. Hybertson B. M., Gao B., Bose S. K., McCord J. M., Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine 2011 32 4-6 234 246 2-s2.0-81855204961 10.1016/j.mam.2011. 10.006
12. Stoner G. D., Wang L., Casto B. C., Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries. Carcinogenesis 2008 29 9 1665 1674 2-s2.0-51849094348 10.1093/carcin/bgn142
13. Reth M., Hydrogen peroxide as second messenger in lymphocyte activation. Nature Immunology 2002 3 12 1129 1134 2-s2.0-0036911138 10.1038/ni1202-1129 (Pubitemid 35469696)
14. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 2007 39 1 44 84 2-s2.0-33749986298 10.1016/j.biocel.2006.07.001 (Pubitemid 44566469)
15. Karunakaran U., Park K. G., A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense. Diabetes and Metabolism Journal 2013 37 2 106 112 10.4093/dmj.2013.37.2.106
16. Bloch-Damti A., Potashnik R., Gual P., Le Marchand-Brustel Y., Tanti J. F., Rudich A., Bashan N., Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress. Diabetologia 2006 49 10 2463 2473 2-s2.0-33748495984 10.1007/s00125-006-0349-6 (Pubitemid 44359109)
17. Finkel T., Signal transduction by reactive oxygen species. Journal of Cell Biology 2011 194 1 7 15 2-s2.0-79960286223 10.1083/jcb.201102095
18. Romeo G. R., Lee J., Shoelson S. E., Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 8 1771 1776 10.1161/ATVBAHA.111.241869
19. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- α in human obesity and insulin resistance. Journal of Clinical Investigation 1995 95 5 2409 2415 2-s2.0-0028931724
20. Stoner H. B., Little R. A., Frayn K. N., The effect of sepsis on the oxidation of carbohydrate and fat. British Journal of Surgery 1983 70 1 32 35 2-s2.0-0020663631 (Pubitemid 13176026)
21. Jang H. J., Kim H. S., Hwang D. H., Quon M. J., Kim J. A., Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin. American Journal of Physiology 2013 304 10 E1077 E1088
22. Tilg H., Moschen A. R., Inflammatory mechanisms in the regulation of insulin resistance. Molecular Medicine 2008 14 3-4 222 231 2-s2.0-41649093318 10.2119/2007-00119.Tilg (Pubitemid 351481853)
23. Liu Z., Cao W., P38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus. Endocrine, Metabolic and Immune Disorders 2009 9 1 38 46 2-s2.0-65549171108 10.2174/187153009787582397
24. Fernández-Veledo S., Nieto-Vazquez I., Vila-Bedmar R., Garcia-Guerra L., Alonso-Chamorro M., Lorenzo M., Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach. Archives of Physiology and Biochemistry 2009 115 4 227 239 2-s2.0-70449411932 10.1080/13813450903164330
25. Jager J., Grémeaux T., Cormont M., Le Marchand-Brustel Y., Tanti J., Interleukin-1 β -induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007 148 1 241 251 2-s2.0-33845873659 10.1210/en.2006-0692 (Pubitemid 46021456)
26. Fessler M. B., Rudel L. L., Brown J. M., Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Current Opinion in Lipidology 2009 20 5 379 385 2-s2.0-73349117487 10.1097/MOL.0b013e32832fa5c4
27. Leemans J. C., Cassel S. L., Sutterwala F. S., Sensing damage by the NLRP3 inflammasome. Immunological Reviews 2011 243 1 152 162 2-s2.0-80052139666 10.1111/j.1600-065X.2011.01043.x
28. de Lima-Salgado T. M., Alba-Loureiro T. C., do Nascimento C. S., Nunes M. T., Curi R., Molecular mechanisms by which saturated fatty acids modulate TNF- α expression in mouse macrophage lineage. Cell Biochemistry and Biophysics 2011 59 2 89 97 2-s2.0-79951850893 10.1007/s12013-010-9117-9
29. Kim F., Tysseling K. A., Rice J., Pham M., Haji L., Gallis B. M., Baas A. S., Paramsothy P., Giachelli C. M., Corson M. A., Raines E. W., Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKK β Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 5 989 994 2-s2.0-20944436777 10.1161/01.ATV.0000160549.60980.a8 (Pubitemid 40627844)
30. Kim F., Pham M., Luttrell I., Bannerman D. D., Tupper J., Thaler J., Hawn T. R., Raines E. W., Schwartz M. W., Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circulation Research 2007 100 11 1589 1596 2-s2.0-34250169823 10.1161/CIRCRESAHA.106.142851 (Pubitemid 46897262)
31. Maloney E., Sweet I. R., Hockenbery D. M., Pham M., Rizzo N. O., Tateya S., Handa P., Schwartz M. W., Kim F., Activation of NF- B by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 9 1370 1375 2-s2.0-69849111863 10.1161/ATVBAHA.109.188813
32. Kim H. P., Pae H., Back S. H., Chung S. W., Woo J. M., Son Y., Chung H., Heme oxygenase-1 comes back to endoplasmic reticulum. Biochemical and Biophysical Research Communications 2011 404 1 1 5 2-s2.0-78650875688 10.1016/j.bbrc.2010.11.067
33. Kim K. M., Pae H., Zheng M., Park R., Kim Y., Chung H., Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circulation Research 2007 101 9 919 927 2-s2.0-37349006900 10.1161/CIRCRESAHA.107.154781 (Pubitemid 350287179)
34. Flamment M., Hajduch E., Ferré P., Foufelle F., New insights into ER stress-induced insulin resistance. Trends in Endocrinology and Metabolism 2012 23 8 381 390 10.1016/j.tem.2012.06.003
35. Özcan U., Cao Q., Yilmaz E., Lee A., Iwakoshi N. N., Özdelen E., Tuncman G., Görgün C., Glimcher L. H., Hotamisligil G. S., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004 306 5695 457 461 2-s2.0-5644231992 10.1126/science.1103160 (Pubitemid 39372439)
36. Bruce C. R., Carey A. L., Hawley J. A., Febbraio M. A., Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003 52 9 2338 2345 2-s2.0-0042822096 10.2337/diabetes.52.9.2338 (Pubitemid 37059505)
37. Ndisang J. F., Jadhav A., Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. American Journal of Physiology 2009 296 4 E829 E841 2-s2.0-65649110522 10.1152/ajpendo.90783.2008
38. Ndisang J. F., Jadhav A., Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 2009 150 6 2627 2636 2-s2.0-66649132533 10.1210/en.2008-1370
39. Ndisang J. F., Lane N., Jadhav A., The heme oxygenase system abates hyperglycemia in zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 2009 150 5 2098 2108 2-s2.0-66449100734 10.1210/en.2008-0239
40. Ndisang J. F., Lane N., Jadhav A., Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. American Journal of Physiology 2009 296 5 E1029 E1041 2-s2.0-66149135526 10.1152/ajpendo.90241.2008
41. Ndisang J. F., Lane N., Syed N., Jadhav A., Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 2010 151 2 549 560 2-s2.0-74949102157 10.1210/en.2009-0471
42. Ndisang J. F., Jadhav A., Fomusi Ndisang J., The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. American Journal of Physiology 2010 298 1 R211 R223 2-s2.0-73549113296 10.1152/ajpregu.91000.2008
43. Poss K. D., Tonegawa S., Heme oxygenase 1 is required for mammalian iron reutilization. Proceedings of the National Academy of Sciences of the United States of America 1997 94 20 10919 10924 2-s2.0-0030886381 10.1073/pnas.94.20. 10919 (Pubitemid 27430836)
44. Orozco L. D., Kapturczak M. H., Barajas B., Wang X., Weinstein M. M., Wong J., Deshane J., Bolisetty S., Shaposhnik Z., Shih D. M., Agarwal A., Lusis A. J., Araujo J. A., Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circulation Research 2007 100 12 1703 1711 2-s2.0-34250831495 10.1161/CIRCRESAHA.107.151720 (Pubitemid 46987862)
45. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. Journal of Clinical Investigation 1999 103 1 129 135 2-s2.0-0032893958 (Pubitemid 29031171)
46. Son Y., Byun S. J., Pae H. O., Involvement of heme oxygenase-1 expression in neuroprotection by piceatannol, a natural analog and a metabolite of resveratrol, against glutamate-mediated oxidative injury in HT22 neuronal cells. Amino Acids 2013 45 2 393 401 10.1007/s00726-013-1518-9
47. Hur J., Kim S., Lee P., Lee Y. M., Choi S. Y., The protective effects of oxyresveratrol imine derivative against hydrogen peroxide-induced cell death in PC12 cells. Free Radical Research 2013 47 3 212 218 10.3109/10715762.2012.762769
48. Clark J. E., Foresti R., Green C. J., Motterlini R., Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochemical Journal 2000 348 3 615 619 2-s2.0-0034660185 10.1042/0264-6021:3480615 (Pubitemid 30410252)
49. Balla G., Jacob H. S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J. W., Vercellotti G. M., Ferritin: a cytoprotective antioxidant strategem of endothelium. Journal of Biological Chemistry 1992 267 25 18148 18153 2-s2.0-0026657174
50. Rahman I., Biswas S. K., Kirkham P. A., Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology 2006 72 11 1439 1452 2-s2.0-33750532308 10.1016/j.bcp.2006.07.004 (Pubitemid 44666744)
51. Otterbein L., Bach F., Alam J., Soares M., Lu H. T., Wysk M., Davis R. J., Flavell R. A., Choi A. M. K., Carbon monoxide has anti-inflammatory effects involving the mitogen- activated protein kinase pathway. Nature Medicine 2000 6 4 422 428 2-s2.0-0034071424 10.1038/74680 (Pubitemid 30208159)
52. Lee T., Chau L., Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nature Medicine 2002 8 3 240 246 2-s2.0-0036127426 10.1038/nm0302-240 (Pubitemid 34250101)
53. Zhang K., Integration of ER stress, oxidative stress and the inflammatory response in health and disease. International Journal of Clinical and Experimental Medicine 2010 3 1 33 40 2-s2.0-77649196117
54. Liu X. M., Peyton K. J., Ensenat D., Wang H., Schafer A. I., Alam J., Durante W., Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle: role in cell survival. Journal of Biological Chemistry 2005 280 2 872 877 2-s2.0-12544253089 10.1074/jbc. M410413200
55. Chung J., Shin D., Zheng M., Joe Y., Pae H., Ryter S. W., Chung H., Carbon monoxide, a reaction product of heme oxygenase-1, suppresses the expression of C-reactive protein by endoplasmic reticulum stress through modulation of the unfolded protein response. Molecular Immunology 2011 48 15-16 1793 1799 2-s2.0-80051928702 10.1016/j.molimm.2011.05.014
56. Li M., Kim D. H., Tsenovoy P. L., Peterson S. J., Rezzani R., Rodella L. F., Aronow W. S., Ikehara S., Abraham N. G., Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008 57 6 1526 1535 2-s2.0-41149155892 10.2337/db07-1764
57. Nicolai A., Li M., Kim D. H., Peterson S. J., Vanella L., Positano V., Gastaldelli A., Rezzani R., Rodella L. F., Drummond G., Kusmic C., L'Abbate A., Kappas A., Abraham N. G., Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 2009 53 3 508 515 2-s2.0-61749098712 10.1161/HYPERTENSIONAHA.108.124701
58. Cao J., Peterson S. J., Sodhi K., Vanella L., Barbagallo I., Rodella L. F., Schwartzman M. L., Abraham N. G., Kappas A., Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet. Hypertension 2012 60 2 467 475
59. Galbraith R. A., Kappas A., Regulation of food intake and body weight in rats by the synthetic heme analogue cobalt protoporphyrin. American Journal of Physiology 1991 261 6 R1388 R1394 2-s2.0-0026354029
60. Csongradi E., Docarmo J. M., Dubinion J. H., Vera T., Stec D. E., Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice. International Journal of Obesity 2012 36 2 244 253 2-s2.0-84857048733 10.1038/ijo.2011.78
61. Dong H. K., Burgess A. P., Li M., Tsenovoy P. L., Addabbo F., McClung J. A., Puri N., Abraham N. G., Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor- α and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. Journal of Pharmacology and Experimental Therapeutics 2008 325 3 833 840 2-s2.0-44249095590 10.1124/jpet.107.135285 (Pubitemid 351724315)
62. Turkseven S., Kruger A., Mingone C. J., Kaminski P., Inaba M., Rodella L. F., Ikehara S., Wolin M. S., Abraham N. G., Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. American Journal of Physiology 2005 289 2 H701 H707 2-s2.0-23744508873 10.1152/ajpheart.00024.2005 (Pubitemid 41129386)
63. Li M., Peterson S., Husney D., Inaba M., Guo K., Eri T., Morita T., Patil K., Kappas A., Ikehara S., Abraham N. G., Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxidants and Redox Signaling 2007 9 7 855 863 2-s2.0-34250343823 10.1089/ars.2007.1568 (Pubitemid 46919588)
64. Ohtomo S., Nangaku M., Izuhara Y., Takizawa S., Strihou C. V. Y. D., Miyata T., Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrology Dialysis Transplantation 2008 23 4 1166 1172 2-s2.0-42949165144 10.1093/ndt/gfm715 (Pubitemid 351767476)
65. Basnet P., Skalko-Basnet N., Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011 16 6 4567 4598 2-s2.0-79959605403 10.3390/molecules16064567
66. Balogun E., Hoque M., Gong P., Killeen E., Green C. J., Foresti R., Alam J., Motterlini R., Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Journal 2003 371 3 887 895 2-s2.0-0037569694 10.1042/BJ20021619 (Pubitemid 36578887)
67. Pae H. O., Jeong G. S., Jeong S. O., Hak S. K., Kim S., Kim Y., Yoo S., Kim H., Chung H., Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells. Experimental and Molecular Medicine 2007 39 3 267 277 2-s2.0-34447134863 (Pubitemid 47037617)
68. Jeong S. O., Oh G. S., Ha H. Y., Koo B. S., Kim H. S., Kim Y., Kim E., Lee K., Chung H., Pae H., Dimethoxycurcumin, a synthetic curcumin analogue, induces heme oxygenase-1 expression through Nrf2 activation in RAW264.7 macrophages. Journal of Clinical Biochemistry and Nutrition 2009 44 1 79 84 2-s2.0-60849126108 10.3164/jcbn.08-194
69. Jeong G. S., Oh G. S., Pae H. O., Jeong S., Kim Y., Shin M., Byeong Y. S., Sang Y. H., Ho S. L., Jeong J., Koh J., Chung H., Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection. Experimental and Molecular Medicine 2006 38 4 393 400 2-s2.0-33748467392
70. Zhongfa L., Chiu M., Wang J., Chen W., Yen W., Fan-Havard P., Yee L. D., Chan K. K., Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemotherapy and Pharmacology 2012 69 3 679 689 2-s2.0-84859741795 10.1007/s00280-011-1749-y
71. Tamvakopoulos C., Dimas K., Sofianos Z. D., Hatziantoniou S., Han Z., Liu Z., Wyche J. H., Pantazis P., Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin. Clinical Cancer Research 2007 13 4 1269 1277 2-s2.0-33947281080 10.1158/1078-0432.CCR-06-1839 (Pubitemid 46424068)
72. Aziz M. T., El Ibrashy I. N., Mikhailidis D. P., Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy. Diabetology & Metabolic Syndrome 2013 5 1 13
73. Chen C. Y., Jang J. H., Li M. H., Surh Y., Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochemical and Biophysical Research Communications 2005 331 4 993 1000 2-s2.0-18844402874 10.1016/j.bbrc.2005.03.237 (Pubitemid 40692459)
74. Szkudelska K., Nogowski L., Szkudelski T., Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. Journal of Steroid Biochemistry and Molecular Biology 2009 113 1-2 17 24 2-s2.0-59849106498 10.1016/j.jsbmb.2008.11.001
75. Rivera L., Morón R., Zarzuelo A., Galisteo M., Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochemical Pharmacology 2009 77 6 1053 1063 2-s2.0-60949087943 10.1016/j.bcp.2008.11.027
76. Rocha K. K., Souza G. A., Ebaid G. X., Seiva F. R. F., Cataneo A. C., Novelli E. L. B., Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food and Chemical Toxicology 2009 47 6 1362 1367 2-s2.0-67349286501 10.1016/j.fct.2009.03.010
77. Palsamy P., Subramanian S., Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β -cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. Journal of Cellular Physiology 2010 224 2 423 432 2-s2.0-77953644361 10.1002/jcp.22138
78. Rodella L. F., Vanella L., Peterson S. J., Drummond G., Rezzani R., Falck J. R., Abraham N. G., Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes. Drug Metabolism Letters 2008 2 4 290 300 2-s2.0-65249172474 10.2174/187231208786734058
79. Penumathsa S. V., Koneru S., Samuel S. M., Maulik G., Bagchi D., Yet S., Menon V. P., Maulik N., Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radical Biology and Medicine 2008 45 7 1027 1034 2-s2.0-51549090151 10.1016/j.freeradbiomed.2008.07.012
80. Thirunavukkarasu M., Penumathsa S. V., Koneru S., Juhasz B., Zhan L., Otani H., Bagchi D., Das D. K., Maulik N., Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radical Biology and Medicine 2007 43 5 720 729 2-s2.0-34547101726 10.1016/j.freeradbiomed.2007.05.004 (Pubitemid 47102122)
81. Piotrowska H., Kucinska M., Murias M., Biological activity of piceatannol: leaving the shadow of resveratrol. Mutation Research 2012 750 1 60 82 2-s2.0-84155167138 10.1016/j.mrrev.2011.11.001
82. Wung B. S., Hsu M. C., Wu C. C., Hsieh C., Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways. Pharmacological Research 2006 53 2 113 122 2-s2.0-29344457837 10.1016/j.phrs.2005.09.006 (Pubitemid 43003477)
83. Kim D. W., Kim Y. M., Kang S. D., Han Y. M., Pae H. O., Effects of resveratrol and trans-3, 5, 4'-trimethoxystilbene on glutamate-induced cytotoxicity, heme oxygenase-1, and sirtuin 1 in HT22 neuronal cells. Biomolecules & Therapeutics 2012 20 3 306 312
84. Yang Y. T., Weng C. J., Ho C. T., Yen G. C., Resveratrol analog-3,5,4′-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Molecular Nutrition and Food Research 2009 53 3 407 416 2-s2.0-62749173154 10.1002/mnfr.200800123
85. Muhoberac B. B., Hanew T., Halter S., Schenker S., A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration. Biochemical Pharmacology 1989 38 22 4103 4113 2-s2.0-0024399033 10.1016/0006-2952(89)90692-8 (Pubitemid 20008749)
86. Rosenberg D. W., Kappas A., The comparative abilities of inorganic cobalt and c cobalt-protoporphyrin to affect copper metabolism and elevate plasma ceruloplasmin. Pharmacology 1995 50 3 201 208 2-s2.0-0028929626
87. Smith T. J., Drummond G. S., Kappas A., Cobalt-protoporphyrin suppresses thyroid and testicular hormone concentrations in rat serum: a novel action of this synthetic heme analogue. Pharmacology 1987 34 1 9 16 2-s2.0-0023103427 (Pubitemid 17029306)
88. Yao P., Nussler A., Liu L., Hao L., Song F., Schirmeier A., Nussler N., Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. Journal of Hepatology 2007 47 2 253 261 2-s2.0-34347392509 10.1016/j.jhep.2007.02.008 (Pubitemid 47023137)
89. Rivera L., Morón R., Sánchez M., Zarzuelo A., Galisteo M., Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity 2008 16 9 2081 2087 2-s2.0-50649107938 10.1038/oby.2008.315